Showing results (491-500 of 542) with videos related to
Sort By:
Pageof 55
The Journal of Infectious Diseases|April 19, 2006
Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapyRonan A M Breen, R F Miller, T Gorsuch, et al.Human Gene Therapy|July 1, 1994
Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteinsL S Laube, M Burrascano, C E Dejesus, et al.Clinicoeconomics and Outcomes Research : CEOR|March 19, 2026
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST StudySatoshi Yoshihara, Aster Meche, Patrick Hlavacek, et al.Arthritis and Rheumatism|June 1, 1992
Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosusB C Richardson, J R Strahler, T S Pivirotto, et al.AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.Nature|January 11, 1990
Very mild muscular dystrophy associated with the deletion of 46% of dystrophinS B England, L V Nicholson, M A Johnson, et al.The Journal of Infectious Diseases|October 21, 1998
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspringJ Moodley, D Moodley, K Pillay, et al.AJR. American Journal of Roentgenology|November 1, 1983
Clinical NMR imaging of the brain in children: normal and neurologic diseaseM A Johnson, J M Pennock, G M Bydder, et al.Thorax|July 18, 2006
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infectionR A M Breen, R F Miller, T Gorsuch, et al.Journal of Medical Genetics|September 1, 1993
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groupsL V Nicholson, M A Johnson, K M Bushby, et al.Pageof 55